News
See our most recent product and company updates.
CASE STUDY: Oral Squamous Cell Carcinoma
Case Presentation: On February 8, 2024, an 8-year-old, spayed female Doberman Pinscher presented with a mass on the right craniolateral mandible. Biopsy samples revealed a squamous cell carcinoma. At the discretion of the veterinarian, 2.0 cc of AlphaFlo® was...
CASE STUDY: Chest Wound
Case Presentation: On May 4, 2022, a two-year-old, spayed female German Shepherd Mix presented with a large wound/ laceration on the sternum. On initial presentation, the patient required tension relieving sutures, as the wound could not be completely closed. The...
CASE STUDY: Calcanean Tendon Lesion (RH)
On September 20, 2021, a 5-year-old, male English Pointer presented with soft tissue swelling with heat noted on point of right hock. The patient was 2/5 lame with some abnormal foot placement with right hind foot. Patient was treated with Low Level Laser Therapy and...
CASE STUDY: Tibial Plateau Leveling Osteotomy
14 Client-owned dogs with naturally occurring rupture of the cranial cruciate ligament underwent Tibial Plateau Leveling Osteotomy (TPLO), performed by Mark Besancon, DVM. Of the 14 dogs, 7 received 1.0 cc of AlphaFlo® intra-articular after closing of the arthrotomy...
CASE STUDY: Acral Lick Dermatitis (LF)
Case Presentation: In January 2024, a 3-year-old Hound Mix dog presented with an erythematous and alopecic skin lesion on the carpal joint of the left front limb. The lesion was diagnosed as an acral lick dermatitis, and the...
CE Seminar The Use of Amnion in Veterinary Practice: Next-Generation Biological Products
Please join us for a live CE Seminar. You will earn 1.0 CE for veterinarians & veterinary technicians. (Approved AAVSB) Attendance is free, and dinner will be provided Date: Tuesday, May 31, 2022 Time: 6:00 PM - 9:00 PM Location: Hilton Garden Inn Conference...
Market Release of AlphaFlo® Canine Allograft
Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.